Milestone Scientific Inc. (MLSS)

ASE – Real vaqt narxi. Valyuta: USD

0.35

-0.05 (-12.52%)

Yopilishda: May 12, 2026, 4:00 PM EDT

0.37

+0.00 (1.05%)

Bozor oldidan: May 13, 2026, 9:07 AM EDT

07.05.2026

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 14, 2026, to discuss the company's financial results for the first quarter ended March 31, 2026, as well as the company's corporate progress and other developments.

07.05.2026

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

ROSELAND, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments, today provided an update on the expansion of its CompuFlo® medical business, highlighting increasing physician utilization, expanding clinical engagement, and continued development of its commercial and reimbursement infrastructure.

21.04.2026

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Financing Strengthens Balance Sheet and Supports Commercial Growth Strategy; Backed by Long-Term Investors Including CEO and Chairman of the Board Financing Strengthens Balance Sheet and Supports Commercial Growth Strategy; Backed by Long-Term Investors Including CEO and Chairman of the Board

01.04.2026

Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript

31.03.2026

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Q4 2025 Marks Transition from Restructuring to Growth For 2026, Expects Double-Digit Revenue Growth, 400% Increase in CompuFlo Sales, and Continued Progress Toward Profitability ROSELAND, N.J., March 31, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ended December 31, 2025.

26.03.2026

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

ROSELAND, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced that it will host a conference call at 8:30 AM Eastern Time on Wednesday, April 1, 2026, to discuss the company's financial results for the fourth quarter and full year ended December 31, 2025, as well as the company's corporate progress and other developments.

23.02.2026

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

ROSELAND, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide objective, pressure-guided precision, today announced the launch of the CompuFlo® Advisor Program.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

21.04.2026

Milestone Scientific Inc. Completes $2.15 Million Private Placement

31.03.2026

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

23.02.2026

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Milestone Scientific Inc. (MLSS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Milestone Scientific Inc. (MLSS)

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Videolar

No Data

Press-relizlar

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Videolar

No Data

Press-relizlar

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Search stocks

Milestone Scientific Inc. (MLSS)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Milestone Scientific Inc. (MLSS)

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Videolar

No Data

Press-relizlar

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Inc. (MLSS) Q4 2025 Earnings Call Transcript

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Schedules Fourth Quarter and FY 2025 Financial Results and Business Update Conference Call

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion

Videolar

No Data

Press-relizlar

Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption

Milestone Scientific Inc. Completes $2.15 Million Private Placement

Milestone Scientific Reports Financial Results for Fourth Quarter and Full Year 2025

Milestone Scientific Launches CompuFlo® Advisor Program to Accelerate Commercial Adoption and Drive Utilization Growth in Select MAC Jurisdictions; Plans National Expansion